Jessica Neely Selected Research

Cytarabine (Cytosar-U)

1/2012

High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica Neely Research Topics

Disease

4	Dermatomyositis (Dermatopolymyositis) 05/2024 - 12/2019
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2020 - 04/2012
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2018 - 01/2013
1	Myositis (Idiopathic Inflammatory Myopathies) 07/2022
1	Rheumatoid Arthritis 01/2021
1	Infarction (Infarctions) 01/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Cytopenia 01/2018
1	Primary Myelofibrosis (Myelosclerosis) 11/2015
1	Chronic Disease (Chronic Diseases) 01/2013
1	Hemorrhage 01/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2012
1	Breast Neoplasms (Breast Cancer) 04/2003

Drug/Important Bio-Agent (IBA)

3	AutoantibodiesIBA 05/2024 - 01/2021
2	Interferon Type IIBA 05/2024 - 11/2023
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	Tyrosine Kinase InhibitorsIBA 05/2020 - 04/2012
1	AntibodiesIBA 07/2022
1	IFIH1 Interferon-Induced HelicaseIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2018
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018
1	Sirolimus (Rapamycin)FDA Link 01/2018
1	Janus Kinase InhibitorsIBA 11/2015
1	Inosine Triphosphate (ITP)IBA 01/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2012

Therapy/Procedure

1	Aftercare (After-Treatment) 05/2020
1	Precision Medicine 12/2019
1	Therapeutics 01/2018
1	Lymph Node Excision (Lymph Node Dissection) 04/2003